NIOX Group PLC - Asset Resilience Ratio
NIOX Group PLC (NIOX) has an Asset Resilience Ratio of 2.63% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of NIOX Group PLC for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2017)
This chart shows how NIOX Group PLC's Asset Resilience Ratio has changed over time. See NIOX net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down NIOX Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NIOX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX10.00 Million | 2.63% |
| Total Liquid Assets | GBX10.00 Million | 2.63% |
Asset Resilience Insights
- Limited Liquidity: NIOX Group PLC maintains only 2.63% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NIOX Group PLC Industry Peers by Asset Resilience Ratio
Compare NIOX Group PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 9.52% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.47% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
Annual Asset Resilience Ratio for NIOX Group PLC (2013–2017)
The table below shows the annual Asset Resilience Ratio data for NIOX Group PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-12-31 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
0.00pp |
| 2017-12-30 | 3.73% | GBX15.00 Million ≈ $1.83K |
GBX402.40 Million ≈ $48.96K |
-2.26pp |
| 2016-12-31 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
0.00pp |
| 2016-12-30 | 5.99% | GBX20.00 Million ≈ $2.43K |
GBX334.10 Million ≈ $40.65K |
-1.74pp |
| 2015-12-31 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
0.00pp |
| 2015-12-30 | 7.73% | GBX37.80 Million ≈ $4.60K |
GBX489.20 Million ≈ $59.52K |
-70.53pp |
| 2014-12-31 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
0.00pp |
| 2014-12-30 | 78.25% | GBX156.90 Million ≈ $19.09K |
GBX200.50 Million ≈ $24.40K |
+59.73pp |
| 2013-12-31 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
0.00pp |
| 2013-12-30 | 18.53% | GBX7.05 Million ≈ $857.42 |
GBX38.03 Million ≈ $4.63K |
-- |
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more